anchor: In the preamble to the rule, FDA presents a summary of its economic analyses, discussing the potential benefits of the proposed rule and the economic impact that could occur as a result of its implementation.
positive: The preamble contains an analysis of the benefits of the rule and its effect on the economy.
negative: There is no preamble to the rule, the FDA neglected to draft one.